Dishman Carbogen Amcis Limited — Important, 12-02-2025: Financial Result Updates

**Consolidated Financial Results Summary:**

- **Total Revenue**: ₹687.97 Cr for the quarter, a growth of 4.67% year-over-year, driven primarily by increased demand across key product segments and successful market expansions.

- **Net Profit**: Reported a profit of ₹4.63 Cr, a significant turnaround compared to a loss of ₹59.63 Cr in the same quarter last year. This shift reflects improved operational efficiency and cost management strategies.

- **Earnings Per Share (EPS)**: EPS stands at ₹0.30, a marked improvement from a loss of ₹3.80 per share in the previous year.

- **Operational Costs**: Total expenses increased marginally to ₹662.96 Cr from ₹723.43 Cr, a decrease of 8.35%, largely due to tighter control on material costs and better inventory management.

- **Balance Sheet Insights**: The company maintains a healthy financial position with total equity increasing slightly to ₹5,568.04 Cr. The debt-equity ratio remains stable at 0.36, indicating a balanced approach to leveraging and sustainable growth.

- **Strategic Outlook**: The focus remains on cost control and innovation in product offerings, with management highlighting opportunities for growth in both domestic and international markets.

- **Investor Insight**: Given the positive trajectory in profitability and effective cost management, a **buy** position seems favorable for investors looking to leverage future growth opportunities in the CDMO sector.

---

*Note: All financial values are presented in crores (Cr) for clarity.*